Current share price for GSK : 1,915.000p 21 (1.11%)+
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
| LON Code | GSK |
| Industry/Sector | Drug Manufacturers - General |
| Market Cap (£M) | 7,746,999 |
| GSK Share Price | 1,915.000p |
| Day High | 1,922.000p |
| Day Low | 1,898.000p |
| Last Close | 1,894.000p |
| GSK Share Price Movement | 21.00p ( 1.11% ) |
Gsk PLC (GSK) is held across 36 ETFs spanning strategies that include drug manufacturers - general exposure . Its weighting in those funds means performance can have an outsized influence - when GSK moves, funds like F100, TLRA, HLTH, DRUG and ALPH that hold it can move with it.
For more concentrated exposure, ETFs such as F100 (BetaShares FTSE 100 ETF) allocate about 2.9% to GSK , while the average exposure across all 36 ETFs that hold it is around 0.6% .
Last updated: ETF data and holdings as at 26 October 2026
How does holding Gsk PLC (GSK) shares directly compare to ETFs that include it?
|
GSK Direct
|
F100
ASX |
TLRA
CBOE |
HLTH
ASX |
DRUG
ASX |
ALPH
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 183 holdings | 30 holdings | 123 holdings | 115 holdings | 62 holdings |
| GSK Weight | 100% | 2.9% | 2.8% | 1.8% | 1.6% | 1.4% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | 0.45% p.a. | 1.28% p.a. | 0.45% p.a. | 0.47% p.a. | 0.65% p.a. |
| Approx. Yield | - | 3.39% | - | 0.32% | 3.67% | 0.75% |
| Star Ratings | - |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not GSK's direct yield. Annual cost uses each ETF's MER.
How a $10,000 investment in Gsk PLC (GSK) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Gsk PLC (GSK) | Direct share | 1,915.000p | 2.82% | +281.88p | 10,281.88p |
| BetaShares FTSE 100 ETF (F100) | Equity - Global | 15.350p | -1.35% | -134.96p | 9,865.04p |
| Talaria Global Equity Fund Complex ETF (TLRA) | Equity - Global Strategy | 5.030p | -0.40% | -39.60p | 9,960.40p |
| VanEck Global Healthcare Leaders ETF (HLTH) | Equity - Global Sectors | 12.380p | 2.91% | +290.94p | 10,290.94p |
| Betashares Global Healthcare ETF - Currency Hedged (DRUG) | Equity - Global Sectors | 9.440p | 2.05% | +205.41p | 10,205.41p |
| Schroder Global Equity Alpha Fund - Active ETF (ALPH) | Equity - Global Strategy | 11.610p | -1.78% | -177.66p | 9,822.34p |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
| ETF | GSK Weight | MER | Yield |
|---|---|---|---|
| BetaShares FTSE 100 ETF (F100) | 2.9% | 0.45% | 3.39% |
| Talaria Global Equity Fund Complex ETF (TLRA) | 2.8% | 1.28% | - |
| VanEck Global Healthcare Leaders ETF (HLTH) | 1.8% | 0.45% | 0.32% |
| Betashares Global Healthcare ETF - Currency Hedged (DRUG) | 1.6% | 0.47% | 3.67% |
| Schroder Global Equity Alpha Fund - Active ETF (ALPH) | 1.4% | 0.65% | 0.75% |
| iShares Europe ETF (IEU) | 0.8% | 0.59% | 8.77% |
| Vanguard FTSE Europe Shares ETF (VEQ) | 0.6% | 0.35% | 2.27% |
| VanEck MSCI International Value ETF (VLUE) | 0.5% | 0.4% | 17.46% |
| iShares MSCI World ex Australia Value ETF (IVLU) | 0.5% | 0.25% | - |
| iShares MSCI World ex Australia Quality ETF (IQLT) | 0.4% | 0.25% | - |
| Operating Revenue Per Share | Price to Operating revenue | Price to free cash flow | Earnings Yield | PE Ratio | Dividend Yield | Forward Dividend Yield | Forward Earnings Yield |
|---|---|---|---|---|---|---|---|
| 10.98p | 174.44p | 1,468.67p | 6.22% | 16.08 | 3.59 | 3.59 | 10.24 |
| Created Date | Changed Date | Event |
|---|---|---|
| n/a | n/a | n/a |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.